Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vatreptacog alfa for joint bleeds in haemophilia with inhibitors
NCT00486278Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2007
- Primary completion
- Jun 2010
- Countries
- 18
01
Overview
A Phase 2 trial of vatreptacog alfa in hemophilia A, Hemophilia B (HB), sponsored by Novo Nordisk. Started Jun 2007; status: completed.
02
Drugs
vatreptacog alfa
03
Conditions
hemophilia AHemophilia B (HB)
Beyond the preview
Go deeper on NCT00486278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486278.